Clinical trial

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

NCT07322965

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-04-01

PhaseNA

Study timeline

Study start (actual)2025-04-01Date precision: day

Registry last updated2026-01-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Primary Open Angle Glaucoma (POAG)unresolved

Neuroprotectionunresolved

Interventions

BrudyGlaucoDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Institut Catala de Retinalead sponsor

Hospital de la Esperanzacollaborator

Mapped research locations

BarcelonaBarcelona, Spain2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07322965 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.